HER2 extracellular domain
US6015567A · kind A · utility
153Cited by
10References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 1995 |
| Grant date | Jan 18, 2000 |
| Priority date | — |
| Expiry date | Apr 14, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a human patient via active immunotherapy comprising administrating an effective amount of extracellular portion of human HER2 receptor to the patient wherein the method provokes a cell-mediated immune response to HER2 receptor in the patient treated therewith.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.